the hope for the gene therapy is--and when we talk about how do we price that it does have to be in the context of what is it costing us to do nothing and, clearly, in your case the cost is almost intolerable.
Discussing the financial implications of gene therapy costs versus inaction.
Share
More from Michael Burgess
I thank Dr. Bucshon from Indiana for yielding me the time on such an important reauthorization that we are undertaking today. Mr. Speaker, 2018 was the last authorization for sickle cell research. Prior to that, it had been part of the…
I thank the gentleman from Georgia for yielding. I rise today to speak in support of the rule and the underlying bills: H.R. 8771, the Department of State, Foreign Operations, and Related Programs Appropriations Act; H.R. 8752, the…
I thank the gentleman for yielding. Mr. Speaker, I do rise today in support of S. 2228, the Building Chips in America Act. Last week, Members of the Texas delegation sent a letter to our leadership requesting that we prioritize this…
I thank my friend for yielding. I rise today in support of this very important rule. Specifically, I rise in support of Israel following the attack on Israel by Iran this past weekend. This direct attack on Israel is unprecedented. It does…
Other voices in this conversation
